Following the announcement of Rein Therapeutics' third-quarter results, its stock price fell 5.6% in the premarket.

Zhitongcaijing · 4d ago
Following the announcement of Rein Therapeutics' third-quarter results, its stock price fell 5.6% in the premarket.